1. 1. Holliday EG, Smith AV, Cornes BK, Buitendijk GH, Jensen RA, Sim X, et al. Insights into the Genetic Architecture of Early Stage Age-Related Macular Degeneration:A Genome-Wide Association Study Meta-Analysis. Plos One 2013;8 (1):e52830.
2. 2. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995; 39:367–74.
3. 3. Lu F, Zhao P, Fan Y, Tang S, Hu J, Liu X, et al. An association study of SERPING1 gene and agerelated macular degeneration in a Han Chinese population. Mol Vis 2010;16:1.
4. 4. Thakkinstian A, McKay GJ, McEvoy M, ChakravarthyU, Chakrabarti S, Silvestri G, et al. Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol 2011;173(12):1365-79.
5. 5. Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinic opathologic correlation of drusen and retinal pigment epithelial abnormalities in age-related macular degeneration. Retina 1994; 14:130–42.
6. 6. Sarks S, Cherepanoff S, Killingsworth M, Sarks J. Relationship of Basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Investig Ophthalmol Vis Sci 2007; 48:968–77.
7. 7. Ferris FL, Davis MD, Clemons TE, Lee L-Y, Chew EY, Lindblad AS, et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;123(11):1570–4.
8. 8. Ratnapriya R CE. Age-related macular degeneration – clinical review and genetics update. Clin Genet 2013;84(2):160-6.
9. 9. Bressler NM. Early Detection and Treatment of Neovascular Age-related Macular Degeneration. J Am Board Fam Pract 2002;15(2):142-52.
10. 10. Meyers SM. A twin study on age related macular degeneration. Trans Am Ophthalmology Soc 1994; 92:775-843.
11. 11. Grizzard SW, Arnett D, and Haag SL. Twin study of age-related macular degeneration. Ophthalalmic Epidemiol 2003; 10:315-22.
12. 12. Dosso AA and Bovet J Monozygotic. twin brothers with age-related macular degeneration. Ophthalmological 1992; 205:24-8.
13. 13. Walport, M.J. Complement First of two parts. N Engl J Med 2001.344, 1058–66.
14. 14. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, et al. Drusen proteome analysis: an approach to the etiology of age related macular degeneration. Proc Natl Acad Sci USA 2002;99:14682–7.
15. 15. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration. Science 2005;308(5270):384-9.
16. 16. Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Gene 2009;46(5):300-7.
17. 17. Nilsson SC, Sim RB, Lea SM, Fremeaux-Bacchi V, Blom AM. Complement factor I in health and disease. Mol Immunol 2011;48(14):1611-20.
18. 18-Wang J, Ohno-Matsui K, Yoshida T, Kojima A, Shimada N, Nakahama K, et al. Altered function of factor I caused by amyloid beta: implication for pathogenesis of age-related macular degeneration. J Immunol 2008; 181:712-20.
19. 19. Kociok, N., Joussen, A.M. Enhanced expression of the complement factor H mRNA in proliferating human RPE cells. Arch Ophthalmol 2010; l(248): 1145–53.
20. 20. Smith C. Genomics: SNPs and human disease. Nature 2005;435(7044):993.
21. 21. Van de Ven JP, Nilsson SC, Tan PL, Buitendijk GH, Ristau T, Mohlin FC, et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet 2013; 45:813-7.
22. 22. Hohenester, E., Sasaki, T. & Timpl, R. Crystal structure of a scavenger receptor cysteine-rich domain sheds light on an ancient superfamily. Nat Struc Mol Biol 1999; 6, 228–32.
23. 23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.
24. 24. Swaroop A., Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009;10: 19-43.
25. 25. Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, et al. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 2006;103(7):2328–33.
26. 26. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000;14(7):835–46.
27. 27. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, Seddon JM. Plasma Complement Components and Activation Fragments: Associations with Age-Related Macular Degeneration Genotypes and Phenotypes. Investig ophthalmol Vis Sci 2009;50(12): 5818-27.
28. 28. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci USA 2010;107(16):7395–400.
29. 29. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 2009;17: 100–4.
30. 30. Ennis S, Gibson J, Cree AJ, Collins A, Lotery AJ: Support for the involvement of complement factor I in age-related macular degeneration. Eur J Hum Genet 2010; 18: 15–6.
31. 31. Philip Alexander, Jane Gibson, Angela J. Cree, Sarah Ennis, Andrew J. Lotery; Complement factor I and age-related macular degeneration. Mol Vis 2014; 20: 1253–7.